Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers

• Published in: Antimicrobial Agents and Chemotherapy Vol. 39; no. 9; pp. 2037 - 2041
• Main Authors: LENFANT, B, NAMOUR, F, LOGEAIS, C, COUSSEDIERE, D, RIVAULT, O, BRYSKIER, A, SURJUS, A
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01.09.1995
• Subjects: Adolescent; Adult; Antibacterial agents; Antibiotics. Antiinfectious agents. Antiparasitic agents; Biological and medical sciences; Cefotaxime; Cefotaxime - administration & dosage; Cefotaxime - analogs & derivatives; Cefotaxime - pharmacokinetics; Cephalosporins; Cephalosporins - administration & dosage; Cephalosporins - pharmacokinetics; Clinical Trial; Half-Life; Humans; Injections, Intravenous; Male; Medical sciences; Pharmacology. Drug treatments; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Spectrophotometry, Ultraviolet; Human; Antibiotic; Intravenous administration; Antibacterial agent; Normal; Pharmacokinetics
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/AAC.39.9.2037

Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC